Molecular Pathways: Can Activin-Like Kinase Pathway Inhibition Enhance the Limited Efficacy of VEGF Inhibitors?

by Bhatt, Rupal S., Atkins, Michael B.
Published 2014

Rapid Development of Hypertension by Sorafenib: Toxicity or Target?

by Humphreys, Benjamin D., Atkins, Michael B.
Published 2009

Future Directions in Renal Cell Carcinoma: 2011 and Beyond

by Cho, Daniel C., Atkins, Michael B.
Published 2011

PD-1 as a potential target in cancer therapy

by McDermott, David F, Atkins, Michael B
Published 2013

Advances in immunotherapy for melanoma

by Redman, Jason M., Gibney, Geoffrey T., Atkins, Michael B.
Published in BMC Med (2016)

Predictive biomarkers for checkpoint inhibitor-based immunotherapy

by Gibney, Geoffrey T, Weiner, Louis M, Atkins, Michael B
Published in Lancet Oncol (2016)

Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy

by Serzan, Michael T, Kumar, Princy N, Atkins, Michael B
Published in J Immunother Cancer (2020)

Management of metastatic renal cell carcinoma in patients with poor prognosis

by Bullock, Andrea, McDermott, David F, Atkins, Michael B
Published 2010

What’s new in melanoma? Combination!

by Ascierto, Paolo A, Marincola, Francesco M, Atkins, Michael B
Published in J Transl Med (2015)

Second‐Line Treatment Landscape for Renal Cell Carcinoma: A Comprehensive Review

by Tannir, Nizar M., Pal, Sumanta K., Atkins, Michael B.
Published in Oncologist (2018)

Indoor Tanning Dependence in Young Adult Women

by Mays, Darren, Atkins, Michael B., Ahn, Jaeil, Tercyak, Kenneth P.
Published in Cancer Epidemiol Biomarkers Prev (2017)

A case of checkpoint inhibitor-induced celiac disease

by Alsaadi, Dana, Shah, Neil J., Charabaty, Aline, Atkins, Michael B.
Published in J Immunother Cancer (2019)

Toxicities of Immunotherapy for the Practitioner

by Weber, Jeffrey S., Yang, James C., Atkins, Michael B., Disis, Mary L.
Published in J Clin Oncol (2015)

Treatment Selection for Patients With Metastatic Renal Cell Carcinoma

by Atkins, Michael B., Choueiri, Toni K., Cho, Daniel, Regan, Meredith, Signoretti, Sabina
Published 2009

Emerging Role of Vedolizumab in Managing Refractory Immune Checkpoint Inhibitor–Induced Enteritis

by Diana, Pietro, Mankongpaisarnrung, Charoen, Atkins, Michael B., Zeck, Jay C., Charabaty, Aline
Published in ACG Case Rep J (2018)

Ipilimumab associated colitis: An IpiColitis case series at MedStar Georgetown University Hospital

by Rastogi, Pawan, Sultan, Mohamed, Charabaty, Aline J, Atkins, Michael B, Mattar, Mark C
Published in World J Gastroenterol (2015)

Support for indoor tanning policies among young adult women who indoor tan

by Mays, Darren, Murphy, Sarah E., Bubly, Rachel, Atkins, Michael B., Tercyak, Kenneth P.
Published in Transl Behav Med (2016)

Evolving impact of long-term survival results on metastatic melanoma treatment

by Michielin, Olivier, Atkins, Michael B, Koon, Henry B, Dummer, Reinhard, Ascierto, Paolo Antonio
Published in J Immunother Cancer (2020)

Correlates of sun safety practices in a racial/ethnically diverse sample of adolescents: Implications for skin cancer prevention interventions

by Mays, Darren, Hawkins, Kirsten B., Tyc, Vida L., Atkins, Michael B., Tercyak, Kenneth P.
Published in Pediatr Dermatol (2015)

Genetic Associations with Indoor Tanning Addiction among non-Hispanic White Young Adult Women

by Mays, Darren, Ahn, Jaeil, Zhang, Bingsong, Atkins, Michael B, Goerlitz, David, Tercyak, Kenneth P
Published in Ann Behav Med (2019)